Search details
1.
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels.
Pharmacol Rev
; 73(4): 298-487, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34753794
2.
Hiding in plain sight: Do recruited dendritic cells surround amyloid plaques in Alzheimer's disease?
Biochem Pharmacol
; : 116258, 2024 May 03.
Article
in English
| MEDLINE | ID: mdl-38705533
3.
Therapeutic potential of N-methyl-D-aspartate receptor modulators in psychiatry.
Neuropsychopharmacology
; 49(1): 51-66, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37369776
4.
Positive allosteric modulation of AMPA receptors from efficacy to toxicity: the interspecies exposure-response continuum of the novel potentiator PF-4778574.
J Pharmacol Exp Ther
; 347(1): 212-24, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23899905
5.
Glutamate receptor ion channels: structure, regulation, and function.
Pharmacol Rev
; 62(3): 405-96, 2010 Sep.
Article
in English
| MEDLINE | ID: mdl-20716669
6.
Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivo.
J Pharmacol Exp Ther
; 341(2): 396-409, 2012 May.
Article
in English
| MEDLINE | ID: mdl-22328573
7.
Phosphodiesterase type 5 (PDE5) inhibition improves object recognition memory: indications for central and peripheral mechanisms.
Neurobiol Learn Mem
; 97(4): 370-9, 2012 May.
Article
in English
| MEDLINE | ID: mdl-22426465
8.
Mechanism for the allosteric regulation of phosphodiesterase 2A deduced from the X-ray structure of a near full-length construct.
Proc Natl Acad Sci U S A
; 106(43): 18225-30, 2009 Oct 27.
Article
in English
| MEDLINE | ID: mdl-19828435
9.
Structural basis for the catalytic mechanism of human phosphodiesterase 9.
Proc Natl Acad Sci U S A
; 105(36): 13309-14, 2008 Sep 09.
Article
in English
| MEDLINE | ID: mdl-18757755
10.
PDE10A Inhibitors-Clinical Failure or Window Into Antipsychotic Drug Action?
Front Neurosci
; 14: 600178, 2020.
Article
in English
| MEDLINE | ID: mdl-33551724
11.
Modulating inhibitory response control through potentiation of GluN2D subunit-containing NMDA receptors.
Neuropharmacology
; 173: 107994, 2020 08 15.
Article
in English
| MEDLINE | ID: mdl-32057801
12.
PTC-174, a positive allosteric modulator of NMDA receptors containing GluN2C or GluN2D subunits.
Neuropharmacology
; 173: 107971, 2020 08 15.
Article
in English
| MEDLINE | ID: mdl-31987864
13.
Molecular mechanism of AMPA receptor noncompetitive antagonism.
Neuron
; 48(2): 279-88, 2005 Oct 20.
Article
in English
| MEDLINE | ID: mdl-16242408
14.
Phosphodiesterase 10 inhibition reduces striatal excitotoxicity in the quinolinic acid model of Huntington's disease.
Neurobiol Dis
; 34(3): 450-6, 2009 Jun.
Article
in English
| MEDLINE | ID: mdl-19281846
15.
Inhibition of Phosphodiesterase 10A Increases the Responsiveness of Striatal Projection Neurons to Cortical Stimulation.
J Pharmacol Exp Ther
; 328(3): 785-95, 2009 Mar.
Article
in English
| MEDLINE | ID: mdl-19056933
16.
Phosphodiesterase 5A inhibitors improve functional recovery after stroke in rats: optimized dosing regimen with implications for mechanism.
J Pharmacol Exp Ther
; 331(3): 842-50, 2009 Dec.
Article
in English
| MEDLINE | ID: mdl-19729580
17.
Cyclic GMP signaling is involved in the luteinizing hormone-dependent meiotic maturation of mouse oocytes.
Biol Reprod
; 81(3): 595-604, 2009 Sep.
Article
in English
| MEDLINE | ID: mdl-19474061
18.
Immunohistochemical localization of phosphodiesterase 2A in multiple mammalian species.
J Histochem Cytochem
; 57(10): 933-49, 2009 Oct.
Article
in English
| MEDLINE | ID: mdl-19506089
19.
Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer's disease.
Bioorg Med Chem Lett
; 19(19): 5703-7, 2009 Oct 01.
Article
in English
| MEDLINE | ID: mdl-19700321
20.
Phosphodiesterases in the CNS: targets for drug development.
Nat Rev Drug Discov
; 5(8): 660-70, 2006 Aug.
Article
in English
| MEDLINE | ID: mdl-16883304